article thumbnail

Immunovant data show potential for autoimmune disease drug

Bio Pharma Dive

Much anticipated clinical trial data for Immunovant’s experimental FcRn inhibitor could catalyze business development decisions for its parent, Roivant Sciences.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Gareth Powell is a business development officer for the NIHR Clinical Research Network (CRN).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Russia: Pfizer stops clinical trials, Bayer halts investment projects

BioPharma Reporter

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

article thumbnail

Clinical trials in Ukraine: Ensuring supply chain continuity during war

Pharmaceutical Technology

The war in Ukraine has had a significant impact on clinical trials in Europe, exacerbating supply chain delays that were already causing multiple problems even before the Covid-19 pandemic intensified the situation. The company operates globally but was founded in Ukraine. We couldn’t put people’s lives at risk.

article thumbnail

Africa: Unleashing the potential of the new superpower in clinical trials

Pharmaceutical Technology

Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. Clinical trials data for Africa Globally, research has found that 62.2% being African American, 3.4%

article thumbnail

Ride4DEI Promotes Stronger Clinical Trial Industry

Velocity Clinical Research

in an effort to raise money and awareness promoting diversity on all levels in clinical trials. But obstacles loom for the plucky bikers, says Sergio Armani, ACRP Ride4DEI Creator, and EVP, Business Development, Helios Clinical Research. Learn more about Velocity's involvement with the ACRP Ride4DEI →.

article thumbnail

The evolution of clinical trials: the pharmaphorum podcast

pharmaphorum

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. Keith Fern joins Elligo with a decade of proven leadership in the CRO industry.